Cibc World Market Inc. Xortx Therapeutics Inc. Transaction History

Cibc World Market Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.73 - $10.71 $2 - $42	4 Added 0.02%	19,043 $16,000
Q3 2022 Nov 10, 2022	SELL	$0.94 - $10.98 $7,483 - $87,411	-7,961 Reduced 29.49%	19,039 $23,000
Q2 2022 Aug 10, 2022	BUY	$1.16 - $1.97 $5,220 - $8,865	4,500 Added 20.0%	27,000 $36,000
Q4 2021 Feb 14, 2022	BUY	$1.8 - $5.84 $40,500 - $131,400	22,500 New	22,500 $46,000

Ticker XRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,389,700
Market Cap $25.2M
Description
XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic ki...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.